Status and phase
Conditions
Treatments
About
Primary objective:
To evaluate the efficacy in terms of oocyte retrieval number of rLH supplement in women with hyporesponse to rFSH after pituitary downregulation.
Secondary objective:
To further explore the efficacy of rLH supplement in women with hyporesponse to rFSH after pituitary downregulation To evaluate the safety of rLH supplementation in hyporesponse women
Full description
Primary endpoint:
Number of oocyte retrieved
Secondary endpoints:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
150 participants in 1 patient group
Loading...
Central trial contact
Jie Qiao, MD, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal